NVDA+2.54%AAPL+1.32%GOOGL−1.62%MSFT+0.20%AMZN−0.10%TSM+1.60%SPCX+7.79%META+0.47%
StockVS

NASDAQ · Health Information Services · USD

Health Catalyst, Inc. (HCAT) Stock Analysis

Health Catalyst, Inc. (HCAT) is a Health Information Services stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 21, 2026

HCAT

$1.74

−$0.01 (−0.57%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare HCAT with… →

HCAT Key Statistics

As of Oct 21, 2026
Trading
Open
$1.74
Previous Close
$1.75
Day's Range
1.74–1.77
52-Week Range
0.96–3.62
Volume
91.72K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
1.54
Valuation
Market Cap
$130.95M
P/E Ratio
unprofitable
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
232.00
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
0.45
EPS (ttm)Profit attributable to each share over the last twelve months.
−3.69
Financials (FY)
Revenue (FY)
$311.14M+1.48%
Net Income (FY)
−$177.97M
Profit marginThe share of revenue left as profit after all costs and taxes.
−90.61%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
75.26M
1-Year Return
−45.28%
Dividend and dates
Earnings Date
November 9, 2026
Avg Volume
611.24K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, HCAT closed at $1.74, −45.28% over 1 year.

Health Catalyst, Inc. (HCAT) has a market capitalization of $130.95M.

In fiscal 2025, HCAT reported revenue of $311.14M.

HCAT Stock Return by Calendar Year

Health Catalyst, Inc. (HCAT) return since Jul 2019: what $10,000 became

1 year
$10,000 $5,472
−45.28%
5 years
$10,000 $337
−96.63%
Since Jul 2019
$10,000 $444
−95.56%

If you had invested $10,000 in Health Catalyst, Inc. (HCAT) at the close on July 25, 2019, the earliest close on record here, it would have been worth $444 at the close on October 21, 2026: −95.56% in total, −34.95% a year, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−27.20%
2025−66.20%
2024−23.65%
2023−12.89%
2022−73.17%
2021−8.98%
2020+25.45%
2019 (partial year)−11.41%

As of October 21, 2026.

HCAT Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$311.14M−$177.97M−57.2%
2024$306.58M−$69.50M−22.7%
2023$295.94M−$118.15M−39.9%
2022$276.24M−$137.40M−49.7%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$311.14M$151.68M−$42.74M−$177.97M−57.2%
2024$306.58M$140.78M−$57.61M−$69.50M−22.7%
2023$295.94M$131.83M−$100.00M−$118.15M−39.9%
2022$276.24M$133.19M−$140.01M−$137.40M−49.7%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

HCAT Valuation vs Health Information Services Median

Median of 44 stocks
MetricHCATHealth Information Services medianvs median
P/S ratio0.452.310.2x the median
Profit margin−90.61%−7.55%83.1 pts below

Medians across 44 Health Information Services stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

All 20 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values Health Catalyst, Inc. (HCAT) at $130.95M. It is classified in the Health Information Services industry, within the Healthcare sector. The company reports 1,200 employees.

The 52-week range on file runs from $0.96 to $3.62. The most recent close on file for HCAT is $1.74, dated October 21, 2026. That is −$0.01 (−0.57%) against the previous close. The latest close sits 82.2% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $311.14M. That is +1.48% against the prior fiscal year, when revenue was $306.58M. The same year closed with a net loss of $177.97M. Profit margin runs at −90.61%. That is 83.1 percentage points below the Health Information Services median of −7.55%. Earnings per share on a trailing basis come to −3.69.

Across the 4 fiscal years on file, revenue moves from $276.24M in 2022 to $311.14M in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

No trailing P/E applies: the last reported earnings figure is negative. The forward P/E on file is 232. The price-to-sales ratio is 0.45. On price-to-sales that is 0.2 times the Health Information Services median of 2.31. The medians here are taken across 44 Health Information Services companies that report the metric.

Over the trailing twelve months the total return is −45.28%. Measured over 5 years, that is −49.24% a year compounded. The reported beta is 1.54. Daily returns over the trailing 7 years annualize to a volatility of 67.76%.

Growth & Income

The record shows no dividend for HCAT.

The strongest complete calendar year on file is 2020 at +25.45%; the weakest is 2022 at −73.17%. Of the 6 complete calendar years on file, 1 finished higher. So far in 2026 the total return is −27.20%.

Peer Comparison

Health Catalyst, Inc. (HCAT) operates in the Health Information Services industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Health Catalyst, Inc. HCAT $130.95M —
Veeva Systems Inc. VEEV $51.90B 52.6
BrightSpring Health Services, Inc. BTSG $12.40B 55.4
Tempus AI, Inc. TEM $12.23B —

The Health Information Services industry average P/E ratio is 46.5x. Health Catalyst, Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Health Information Services Stocks

VEEV

Veeva Systems Inc.

$51.90B

 BTSG

BrightSpring Health Services, Inc.

$12.40B

 TEM

Tempus AI, Inc.

$12.23B

 HNGE

Hinge Health, Inc.

$9.04B

 HQY

HealthEquity, Inc.

$8.10B

 DOCS

Doximity, Inc.

$5.99B
View all Health Information Services stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

 JNJ

Johnson & Johnson

$621.22B

 ABBV

AbbVie Inc.

$503.27B

 UNH

UnitedHealth Group Incorporated

$374.30B

 MRK

Merck & Co., Inc.

$369.78B
View all Healthcare stocks →

About Health Catalyst, Inc.

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. The company operates in two segments: Technology and Professional Services. It offers ignite data and analytics platform that provides clients a single comprehensive environment to integrate and organize data from their disparate software systems; and applications, a software analytics applications build for ignite platform to analyze clients face across clinical improvement, revenue and cost improvement, ambulatory operations, measures and registries, and data and analytics. The company also provides expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. It serves academic medical centers, integrated delivery networks, community hospitals, large physician practices, accountable care organizations, health information exchanges, health insurers, life science organizations, healthcare technology vendors, and other risk-bearing entities. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.

Visit website →